This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alexza Pharmaceuticals Inc (ALXA)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -21.31M -36.73M -39.62M -27.98M
Operating Gains/Losses 0.00 8.00K -15.00K -415.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 173.00K -44.00K -129.00K 10.00M
(Increase) Decrease in Inventories 2.50M -282.00K -3.45M 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 200.00K
(Decrease) Increase In Payables -1.36M -1.99M 1.64M -1.46M
(Decrease) Increase In Other Current Liabilities 558.00K 654.00K 1.12M 559.00K
(Increase) Decrease In Other Working Capital -1.46M -341.00K -4.46M -6.83M
Other Non-Cash Items -15.17M -7.72M 40.48M 3.10M
Net Cash From Continuing Operations -31.88M -41.50M -612.00K -18.24M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -31.88M -41.50M -612.00K -18.24M
Sale of Property, Plant & Equipment 15.00K 0.00 16.00K 425.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 25.29M 30.84M 10.65M 2.00M
Purchases of Property, Plant & Equipment -58.00K -2.36M -1.78M -452.00K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -5.80M -42.00M -19.23M 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 19.45M -13.53M -10.35M 1.97M
Issuance of Debt 2.91M 50.83M 15.00M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 182.00K 5.88M 6.58M 35.24M
Repayment of Long-Term Debt 0.00 -781.00K -5.77M -6.11M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 1.89M -3.01M -5.26M -10.05M
Net Cash From Financing Activities 4.99M 52.92M 10.55M 19.08M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -7.45M -2.11M -409.00K 2.81M
ALXA News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ALXA Alexza Pharmaceuticals Inc

Chart of ALXA

Analysts Ratings for ALXA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 1 1
Moderate Buy 0 0 0 0
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ALXA ANALYST REPORT

ALXA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs